PEMBROLIZUMAB for Soft tissue sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 26 adverse event reports in the FDA FAERS database where PEMBROLIZUMAB was used for Soft tissue sarcoma.

Most Reported Side Effects for PEMBROLIZUMAB

Side Effect	Reports	%	Deaths	Hosp.
Malignant neoplasm progression	10,111	12.1%	5,124	3,426
Death	4,744	5.7%	4,737	893
Diarrhoea	4,251	5.1%	556	2,141
Fatigue	3,833	4.6%	365	1,246
Off label use	3,416	4.1%	747	1,045
Product use in unapproved indication	3,191	3.8%	514	909
Pyrexia	3,155	3.8%	444	2,194
Rash	2,900	3.5%	289	1,047
Nausea	2,670	3.2%	335	1,237
Decreased appetite	2,486	3.0%	371	1,235
Hypothyroidism	2,326	2.8%	242	935
Product use issue	2,323	2.8%	417	610
Hypertension	2,245	2.7%	276	1,118
Asthenia	2,131	2.5%	300	1,058
Interstitial lung disease	2,113	2.5%	869	1,276